Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.6 CHF | -0.69% | +0.28% | +40.67% |
Apr. 25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Mar. 20 | Transcript : Cosmo Pharmaceuticals N.V. - Analyst/Investor Day |
Sales 2023 | 96.72M 103M 94.5M | Sales 2024 * | 262M 280M 256M | Capitalization | 1.18B 1.26B 1.15B |
---|---|---|---|---|---|
Net income 2023 | 1M 1.07M 977K | Net income 2024 * | 111M 119M 108M | EV / Sales 2023 | 8.6 x |
Net cash position 2023 | 48.44M 51.79M 47.32M | Net cash position 2024 * | 110M 118M 108M | EV / Sales 2024 * | 4.07 x |
P/E ratio 2023 |
771
x | P/E ratio 2024 * |
10.6
x | Employees | 319 |
Yield 2023 |
3.65% | Yield 2024 * |
2.86% | Free-Float | 44.49% |
Latest transcript on Cosmo Pharmaceuticals N.V.
1 day | -0.69% | ||
1 week | +0.28% | ||
Current month | +0.42% | ||
1 month | +10.15% | ||
3 months | +14.56% | ||
6 months | +111.52% | ||
Current year | +40.67% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 05-12-31 | |
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 16-05-31 |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David W Maris
BRD | Director/Board Member | 57 | 21-05-27 |
Founder | 69 | 96-12-31 | |
Director/Board Member | 64 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 773 M€ | -.--% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 71.6 | -0.69% | 4,709 |
24-04-25 | 72.1 | -4.25% | 14,274 |
24-04-24 | 75.3 | +1.21% | 17,185 |
24-04-23 | 74.4 | +1.36% | 26,912 |
24-04-22 | 73.4 | +2.80% | 21,855 |
Delayed Quote Swiss Exchange, April 26, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.67% | 1.27B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- COPN Stock